Search
Blog Post
Hyundai Hope on Wheels funds research for acute lymphoblastic leukemia (ALL)
News
Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-Cell Therapy in Two Pediatric Leukemias
… Therapy in Two Pediatric Leukemias Roswell Park’s Dr. Lisa Niswander presents research results at American Society of … KMT2A-rearranged acute lymphoblastic leukemia (ALL). Lisa Niswander, MD, PhD , Assistant Professor of Oncology in the … toxicities and improve long-term remission,” says Dr. Niswander. “Our preclinical studies take a two-pronged …
News
Hyundai Hope On Wheels Awards $100,000 to Roswell Park to Fund Infant Leukemia Immunotherapy Research
Pediatric Cancer Care Team
… Matthew Barth, MD Pediatric Hematology/Oncology Lisa Niswander, MD, PhD Pediatric Hematology/Oncology Erin Hughes, …
Department of Immunology Faculty
… Oncology Shared Resource Department of Immunology Lisa Niswander, MD, PhD Assistant Professor of Oncology Kazuaki …
Clinical Trial
(AALL2321) A Phase 2 Study of Blinatumomab in Combination with Chemotherapy for Infants with Newly Diagnosed Acute Lymphoblastic Leukemia with Randomization of KMT2A-Rearranged Patients to Addition of Venetoclax
Tumor Immunology & Immunotherapy Program Members
… Group Department of Immunology View the Nemeth Lab Lisa Niswander, MD, PhD Assistant Professor of Oncology Scott …
Research
Translational Research Groups
Clinical Trial